Codex DNA Announces Plan to Change Corporate Name to Telesis Bio
12 Oct 2022 //
GLOBENEWSWIRE
Codex DNA Reports Second Quarter 2022 Financial Results
09 Aug 2022 //
GLOBENEWSWIRE
Codex DNA to Present at the 2022 Jefferies Healthcare Conference
02 Jun 2022 //
GLOBENEWSWIRE
Codex DNA Showcases Automated Synthetic Biology Solutions
01 Jun 2022 //
GLOBENEWSWIRE
Codex DNA Reports First Quarter 2022 Financial Results
10 May 2022 //
GLOBENEWSWIRE
Codex DNA to Report First Quarter 2022 Financial Results
03 May 2022 //
GLOBENEWSWIRE
Codex DNA Unveils Automated Synthetic Biology Solutions for Ab and Protein
27 Apr 2022 //
GLOBENEWSWIRE
Codex DNA shows Simple, Scalable, and Cell-Free Approach to Rapid mRNA Vaccine
18 Apr 2022 //
GLOBENEWSWIRE
Codex DNA to Showcase Innovative SOLA Enzymatic DNA Synthesis Technology
06 Apr 2022 //
GLOBENEWSWIRE
Codex DNA Reports Q4 and Full Year 2021 Financial Results
22 Mar 2022 //
GLOBENEWSWIRE
Codex DNA Announces Registration and Webcast Information
03 Mar 2022 //
GLOBENEWSWIRE
Codex DNA to Report Q4 2021 Financial Results on March 22
02 Mar 2022 //
GLOBENEWSWIRE
Codex DNA to Present at the Cowen 42nd Annual Healthcare Conference
24 Feb 2022 //
GLOBENEWSWIRE
Codex DNA to Participate in the SVB Leerink 11th Annual Conference
09 Feb 2022 //
GLOBENEWSWIRE